go back

Ondansetron, Oral

Tennessee rates for HCPCS Q0162

Ondansetron 1 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$320%10%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%$0$0.0$0.1$0.5$2.0$10.0$50.0$200.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.08
Typical High
$14.13
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$0.04
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$85.11
Median
$85.11
Typical High
$85.11
Lucent Health
Setting
Professional
Modifier
Global
Typical Low
$524.81
Median
$524.81
Typical High
$524.81
United
Setting
Facility
Modifier
Global
Typical Low
$0.03
Median
$0.04
Typical High
$0.04
United
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$4.37
Typical High
$5.13